Investment Vehicle

Developing an early stage therapeutic asset? Access strategic investments from InSymbiosis as part of your fundraising strategy.


Our Investment Vehicle

InSymbiosis’ Investment Vehicle (formalized in 2016 as InSynchrony Ventures Inc.) tactically combines InSymbiosis’ successful business model with our desire to accelerate promising early stage drug assets towards clinical proof of concept and strategic exits.

Visit InSynchrony Ventures

Investment Opportunities

As investors, we are opportunistic and we therefore do not have a particular therapeutic bias. We are interested in meeting companies with therapeutic products in development that have achieved a minimum of animal proof of concept and have a clearly defined drug development plan and commercial exit strategy.